Volume 9, Issue 3 ( September 2017 2017)                   Iranian Journal of Blood and Cancer 2017, 9(3): 75-79 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mehrazmay M, Mojtahedi Z, Malekzadeh M, Taghipour M, Ghaderi A. Serum Levels of Glial Fibrillaryacidic Protein in Meningioma. Iranian Journal of Blood and Cancer 2017; 9 (3) :75-79
URL: http://ijbc.ir/article-1-743-en.html
1- Shiraz University of Medical Sciences
2- Shiraz University of Medical Sciences , ghaderia@sums.ac.ir
Abstract:   (4500 Views)

Background: Glial fibrillaryacidic protein (GFAP), an intermediate filament protein, is mainly expressed by astrocytes, but some other cells like enteric glia and non-myelinating Schwann cells can also express GFAP. GFAP elevation has been reported in some types of meningioma and malignant brain tumors. In the present study, we analyzed the association between serum levels of GFAP with meningioma. 
Methods: Sixty-eight newly diagnosed patients with meningioma and 28 healthy individuals (control group) were included. Serum levels of GFAP were measured by ELISA.
Results: There was no significant difference in GFAP serum levels between the two groups. Subdivision of the patients also revealed no significant association between GFAP and meningioma. 
Conclusion: We studied serum levels of GFAP in meningioma in Iranian patients for the first time. We did not observe a significant association between meningioma and GFAP. A larger study including a larger number of different subtypes of meningioma patients may discover a weakly significant difference if it exists.

Keywords: Brain, GFAP, Meningioma, Serum
Full-Text [PDF 462 kb]   (1776 Downloads)    
: Original Article | Subject: Adults Hematology & Oncology
Received: 2017/06/23 | Accepted: 2017/10/9 | Published: 2017/11/25

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 All Rights Reserved | Iranian Journal of Blood and Cancer

Designed & Developed by : Yektaweb